T0	Participants 127 156	patients with duodenal ulcer.
T1	Participants 233 252	two parallel groups
T2	Participants 629 658	patients with duodenal ulcer.
T3	Participants 659 803	Thirty patients were included, divided into two groups of 15, to whom one of the study therapies was administered based on a randomization code.